Quyen Q Hoang

Title: Quyen Q Hoang: Innovator in Protein Interaction Inhibition

Introduction

Quyen Q Hoang is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that mimic protein structures. With a total of 2 patents, his work has the potential to impact drug development and disease treatment.

Latest Patents

One of his latest patents is titled "Alpha-helix analog having triazine-piperazine backbone and method for preparing same." This patent describes an alpha-helix mimetic compound that efficiently mimics the alpha-helix structure of protein secondary structures. The compound acts as an inhibitor for protein interactions, which can be specific to various diseases mediated by alpha-helix structures. This innovation holds promise as a biological probe and has a high potential for drug treatment of diseases.

Another significant patent is "Ice-cleaved alpha-synuclein as a biomarker." This disclosure provides ICE-cleaved alpha-synuclein fragments as biomarkers for alpha-synuclein-associated diseases or disorders, as well as for ICE-regulator therapy.

Career Highlights

Quyen Q Hoang has worked with esteemed institutions, including the Pohang University of Science and Technology Foundation and Posco. His experience in these organizations has contributed to his expertise in the field of biochemistry and innovation.

Collaborations

Quyen has collaborated with notable colleagues, including Wei Wang and Hyun-Suk Lim. Their joint efforts have further advanced research in the area of protein interactions and disease treatment.

Conclusion

Quyen Q Hoang is a distinguished inventor whose work in developing innovative compounds has the potential to revolutionize the treatment of diseases. His contributions to the field of biochemistry are noteworthy and continue to inspire future research and development.